Literature DB >> 9489593

Clinical aspects of indocyanine green pharmacokinetics following portal vein administration.

S Nishi1, M Shindo, J Abe, A Asada.   

Abstract

AIMS: This study was performed to demonstrate that measurement of the clearance of indocyanine green (ICG) following portal vein administration (CLpv) is more useful than that following peripheral vein administration (CLiv) for evaluating intrinsic clearance and hepatic blood flow.
METHODS: Eight patients, aged 55.9 +/- 8.8 years, who underwent partial hepatectomy were studied. ICG was administrated to all patients via peripheral and portal veins before and after enflurane anaesthesia and soon after surgery. ICG concentrations were measured by h.p.l.c. Non-compartmental analysis was applied to the ICG time-concentration data obtained. The area under the curve (AUC), clearance (CL), mean residence time (MRT) and volume of distribution (V) were calculated using this method of analysis.
RESULTS: CLpv was significantly decreased from 26.4 +/- 13.2 ml kg(-1) min(-1) before anaesthesia, to 19.5 +/- 7.0 (P < 0.05) and 12.7 +/- 5.3 (P < 0.01) ml kg(-1) min(-1), respectively, during anaesthesia and after partial hepatectomy; These values were 72.1% (P < 0.01) and 48.5% (P < 0.01) of that observed at percutaneous transhepatic portography (PTP). CLiv was significantly decreased from 14.6 +/- 5.3 ml kg(-1) min(-1) before anaesthesia, to 9.4 +/- 3.6 (P < 0.05) and 9.8 +/- 4.1 (P < 0.05) ml kg(-1) min(-1), respectively, after partial hepatectomy and 12 h after operation; These values were 68.9% (P < 0.05) and 73.5% (P < 0.05) of the value at PTP. The other pharmacokinetic parameters examined, V and MRT, did not change significantly during anaesthesia or after surgery.
CONCLUSION: The clearance of ICG after portal administration was useful for estimating hepatic blood flow and intrinsic clearance in perioperative management of liver surgery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489593      PMCID: PMC1873989          DOI: 10.1046/j.1365-2125.1998.00641.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.

Authors:  M S Roberts; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

Review 3.  Clearance approaches in pharmacology.

Authors:  G R Wilkinson
Journal:  Pharmacol Rev       Date:  1987-03       Impact factor: 25.468

Review 4.  Effects of liver disease on drug disposition in man.

Authors:  G R Wilkinson; S Schenker
Journal:  Biochem Pharmacol       Date:  1976-12-15       Impact factor: 5.858

5.  Hepatic transport kinetics and plasma disappearance curves: distributed modeling versus conventional approach.

Authors:  E L Forker; B Luxon
Journal:  Am J Physiol       Date:  1978-12

6.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

7.  Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.

Authors:  K S Pang; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

Review 8.  Propranolol disposition in chronic liver disease: a physiological approach.

Authors:  R A Branch; D G Shand
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  Determinants of drug disposition in patients with cirrhosis.

Authors:  P M Huet; J P Villeneuve
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

10.  Effects of combined extradural blockade and general anaesthesia on indocyanine green clearance and halothane metabolism.

Authors:  C Nancarrow; J L Plummer; A H Ilsley; C F McLean; M J Cousins
Journal:  Br J Anaesth       Date:  1986-01       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.